Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
MGA’s Alex Brill Serves as a Panelist for “Biosimilars: Breaking Through the Barriers” Symposium

MGA’s Alex Brill Serves as a Panelist for “Biosimilars: Breaking Through the Barriers” Symposium

Mar 25, 2020 | Events

Alex Brill was one of the panelists discussing his “commitment to expand biosimilar use in the United States and how physicians and government officials are looking to help.

  • Analysis (42)
  • Books (3)
  • Commentary (4)
  • Events (16)
  • Interviews (55)
  • News (54)
  • Op-Eds (82)
  • Press Releases (4)
  • Testimony (20)
  • Regulatory Uncertainty for ESOPs
    New MGA White Paper Examines Consequences of Regulatory Uncertainty for Employee OwnershipOctober 2, 2023
  • PBMs in US Drug Pricing Debate
    MGA Releases White Paper on Role of PBMs in US Drug Pricing DebateSeptember 26, 2023
  • Unintended Consequences of Limiting PBMsSeptember 26, 2023
  • Importance of Prescription Drug Rebates
    ‘The Price of Business’: A Major Fiscal Crisis is Brewing and Largely Ignored by the MediaAugust 11, 2023
  • Congress takes on PBMs
    1 big thing: Congress takes on PBMsAugust 9, 2023
  • Here comes Humira competition
    Here comes Humira competition July 20, 2023
  • Humira Competitors Don’t Guarantee
    Humira Competitors Don’t Guarantee Lower Patient Drug CostsJuly 19, 2023
  • The State of Biosimilars
    The State of Biosimilars: What to WatchJuly 18, 2023
  • Importance of Prescription Drug Rebates
    ‘The Price of Business’: Discussing the Latest Inflation ReportJuly 12, 2023
  • Brill discusses adalimumab market
    Alex Brill Interviewed on the Future of the Adalimumab Market June 28, 2023
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact